Results 111 to 120 of about 386,776 (309)
Case series of a novel inflammatory bowel disease phenotype (UC2CD) in Mexican patients
Revista de Gastroenterología de México (English Edition)A novel inflammatory bowel disease phenotype, named UC2CD, was recently described and is characterized by the transformation from ulcerative colitis (UC) to the Crohn’s disease (CD) phenotype, with distinct clinical, serologic, and genetic features.
J.K. Yamamoto-Furusho +3 more
doaj +1 more source
Arthritis &Rheumatology, EarlyView.Objective The gut–joint axis is a central paradigm in spondyloarthritis, yet the cellular mechanisms linking intestinal and joint immunity remain poorly understood. One potential link is T cell receptor αβ+ CD4+ colon intraepithelial lymphocytes (cIELs) that can traffic to extraintestinal tissues, including the joint.
Sarah M. Danielson +4 more
wiley +1 more source
La malattia e il male senza uscita in 'Literatura + enfermedad = enfermedad' di Roberto Bolaño
, 2012 il tema della malattia nell'opera di Roberto Bolaño, a partire dalla dissertazione "Literatura + enfermedad = enfermedad", in El gaucho ...
Masotti, Andrea
core +1 more source
Polimorfismos genéticos de interleucina-22 en pacientes con colitis ulcerosa
Revista de Gastroenterología de México, 2016 Antecedentes: La colitis ulcerosa (CU) es una enfermedad multifactorial y poligénica. La interleucina (IL) 22 es una citocina inmunomoduladora que pertenece a la familia de IL-10.
J.K. Yamamoto-Furusho +3 more
doaj +1 more source
Research needs for Chagas disease prevention.
, 2010 We present an overview of the two main strategies for the primary (vector control) and secondary (patient care) prevention of Chagas disease (CD). We identify major advances, knowledge gaps, and key research needs in both areas.
Santos, Walter S +6 more
core +1 more source
Lenacapavir initiation with concomitant primidone: A case report with therapeutic drug monitoring
British Journal of Clinical Pharmacology, EarlyView.Lenacapavir (LEN), a first‐in‐class capsid inhibitor, has unique pharmacokinetics that enable twice‐yearly dosing. LEN is not extensively metabolized, although it is a substrate of CYP3A4, which introduces drug–drug interactions concerns. As adoption and implementation of LEN for treatment and prevention increase, additional guidance on concomitant ...
Aaron S. Devanathan +6 more
wiley +1 more source
, 2012 Volante invitación curso taller detección temprana de enfermedad renal crónica y su manejo ...
Cristerna González, Ana Cristina
core +1 more source
Anticuerpos antitransglutaminasa no relacionados con la ingesta de gluten
Anales de Pediatría, 2018 Resumen: Introducción: Los anticuerpos antitransglutaminasa (ATG) poseen alta especificidad para el diagnóstico de enfermedad celíaca (EC). Sin embargo, se han descrito anticuerpos ATG positivos en pacientes no celíacos.
Mónica Garcia-Peris +5 more
doaj +1 more source
Farmacoterapia en la enfermedad renal [PDF]
, 2017 Uno de los pilares del tratamiento de las personas con Enfermedad Renal es la administración de drogas que aporten elementos inadecuadamente metabolizados por el riñón o minimicen otras complicaciones propias de la enfermedad.
Sarria Guerrero, José Antonio +3 more
core +1 more source